e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Pulmonary circulation II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Four year experience of a dedicated connective tissue disorder pulmonary hypertension clinic
R. Lee, R. Martin, G. Coghlan, D. D‘Cruz (London, United Kingdom)
Source:
Annual Congress 2009 - Pulmonary circulation II
Session:
Pulmonary circulation II
Session type:
Thematic Poster Session
Number:
3927
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Lee, R. Martin, G. Coghlan, D. D‘Cruz (London, United Kingdom). Four year experience of a dedicated connective tissue disorder pulmonary hypertension clinic. Eur Respir J 2009; 34: Suppl. 53, 3927
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Refining definitions of time to clinical worsening in connective tissue disease-associated pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
1 year evolution of pulmonary hypertension in patients with connective tissue diseases and secondary antiphospholipid syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 280s
Year: 2004
Single centre experience of connective tissue disease (CTD) associated pulmonary arterial hypertension (PAH): Impact of a supra-regional screening programme
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
Pulmonary involvement in patients diagnosed with inflammatory joint and connective disease in a multidisciplinary outpatient surgery
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010
Clinical and polysomnographic findings in patients with connective tissue disease and pulmonary hypertension
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
Exercise training in pulmonary arterial hypertension associated with connective tissue diseases
Source: Annual Congress 2012 - Limiting factors in exercise
Year: 2012
Connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment
Source: Eur Respir Rev 2014; 23: 505-509
Year: 2014
Pulmonary arterial hypertension associated with connective tissue disease: an integrated approach
Source: Annual Congress 2008 - Mastering pulmonary arterial hypertension: defined by evidence - enhanced by experience
Year: 2008
Pulmonary arterial hypertension in connective tissue diseases
Source: Eur Respir Mon 2012; 57: 42-57
Year: 2012
Ambrisentan therapy for patients with PAH associated with connective tissue disease (PAH-CTD): one year follow-up
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008
Veno-occlussive lesions and inflammation in pulmonary arterial hypertension associated with connective tissue diseases
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007
Social deprivation in Scottish populations with pulmonary hypertension secondary to connective tissue disease and chronic thromboembolic disease
Source: ERJ Open Res, 6 (4) 00297-2019; 10.1183/23120541.00297-2019
Year: 2020
A decade of activity in treating patients with pulmonary arterial hypertension in Timisoara center
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019
Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis. A tissue doppler imaging study
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
Heritable connective tissue disorders as factor modifying asthma symptoms in pediatric patients
Source: Annual Congress 2012 - Asthma management
Year: 2012
Significance of connective tissue disease in a typical UK diffuse parenchymal lung disease clinic
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007
Choosing pharmacotherapy for ILD in patients with connective tissue disease
Source: Breathe, 17 (4) 210114; 10.1183/20734735.0114-2021
Year: 2021
Acute effects of oxygen on pulmonary hemodynamic can help in differentiation of pulmonary hypertension at patients with connective tissue diseases
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Managing pregnancy in pulmonary hypertension using a multi-professional approach: a 16-year experience in a specialist referral centre
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Early risk prediction in idiopathic
versus
connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment
Source: ERJ Open Res, 7 (3) 00854-2020; 10.1183/23120541.00854-2020
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept